Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
暂无分享,去创建一个
G. Sobue | J. Kira | N. Atsuta | M. Katsuno | R. Yamasaki | Tomohiko Nakamura | M. Hirayama | H. Koike | S. Ikeda | Y. Kawagashira | M. Iijima | R. Nishi | H. Ogata
[1] D. Sherman,et al. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies , 2017, Neuromuscular Disorders.
[2] J. Devaux,et al. Teaching NeuroImages: Cranial nerve hypertrophy in IgG4 anti-neurofascin 155 antibody–positive polyneuropathy , 2017, Neurology.
[3] G. Sobue,et al. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies , 2017, Journal of Neurology, Neurosurgery & Psychiatry.
[4] E. Nagata,et al. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay , 2016, Journal of Neuroimmunology.
[5] J. Devaux,et al. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. , 2016, Brain : a journal of neurology.
[6] N. Kokubun,et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy , 2016, Neurology.
[7] A. Hiwatashi,et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy , 2015, Annals of clinical and translational neurology.
[8] R. Rojas-García,et al. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins , 2015, Neurology: Neuroimmunology & Neuroinflammation.
[9] N. Yuki,et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. , 2015, Brain : a journal of neurology.
[10] S. Dib-Hajj,et al. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[11] H. Watanabe,et al. Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment , 2014, European journal of neurology.
[12] R. Blesa,et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg , 2014, Neurology.
[13] G. Nogales-Gadea,et al. Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy , 2013, Annals of neurology.
[14] J. Schwab,et al. Neurofascin as a target for autoantibodies in peripheral neuropathies , 2012, Neurology.
[15] C. Sommer,et al. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition , 2010, The Lancet Neurology.
[16] J. Pollard,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision , 2010, European journal of neurology.
[17] M. Bhat,et al. Spatiotemporal ablation of myelinating glia‐specific neurofascin (NfascNF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains , 2009, Journal of neuroscience research.
[18] H. Watanabe,et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[19] M. Kubota,et al. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[20] G. Sobue,et al. Age associated axonal features in HNPP with 17p11.2 deletion in Japan , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[21] Elior Peles,et al. Contactin Orchestrates Assembly of the Septate-like Junctions at the Paranode in Myelinated Peripheral Nerve , 2001, Neuron.
[22] K. Petry,et al. Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. , 2000, Ultrastructural pathology.
[23] M. Noda,et al. IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome , 1998, Annals of neurology.
[24] J. Mcleod,et al. Chronic relapsing polyneuritis , 1976, Journal of the Neurological Sciences.
[25] P. Dyck,et al. Chronic inflammatory polyradiculoneuropathy. , 1975, Mayo Clinic proceedings.
[26] C. Krarup,et al. Chronic inflammatory demyelinative polyneuropathy. , 2013, Handbook of clinical neurology.